Cedar Wealth Management, LLC Astrazeneca PLC Transaction History
Cedar Wealth Management, LLC
- $276 Million
- Q4 2024
A detailed history of Cedar Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cedar Wealth Management, LLC holds 534 shares of AZN stock, worth $40,263. This represents 0.01% of its overall portfolio holdings.
Number of Shares
534
Previous 534
-0.0%
Holding current value
$40,263
Previous $41,000
17.07%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...